Study identifier:D5162R00036
ClinicalTrials.gov identifier:NCT06376097
EudraCT identifier:N/A
CTIS identifier:N/A
Implementation of a lung cancer screening program in a public service, using low-dose tomography and metabolomics evaluation
lung cancer
Phase 4
No
-
All
1000
Observational
45 Years - 74 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|